I am sure that most people that are curious about cancer, or know of a loved one that has gone through the entire cancer ordeal, and more specifically Breast Cancer, have heard of the term HER2neu or if their breast cancer was referred to as HER2 + (positive) or - (negative). In cancer care, there happens to be a lot of acronyms and terms thrown out there, or perhaps your physician uses them often, so...
I apologize due to the late postings. I have been in San Francisco this week for a breast cancer symposium and am writing these in the late hours of the night. I know there are a few emails I need to return to patients, but will reply tomorrow when I return home. I will have more time to ensure that I properly email all the information that you need. My sincere apologies. Today I would like...
I have been working in the cancer field for almost ten years now. I have heard a lot of myths or rumors, and this is yet another one. There is nothing scientifically shown nor is there any data driven studies done that have proved aluminum or anything in deodorants to cause cancer, let alone breast cancer. We all have to remember that in order for a product to be placed on the market, it must first...
As I mentioned in yesterday's blog on Mammosite, today I was going to talk a little more in depth about the phase III randomized trial that is underway. This NSABP-RTOG Phase III trial is entitled: Conventional Whole Breast Irradiation versus Partial Breast Irradiation for Women with Stage 0, 1, or 2 Breast Cancer. The protocol number respectively are: NSABP-B39 and RTOG-0413. The purpose of this trial is to evaluate the difference, if any, between women that...
Since it is Breast Cancer Awareness month I think it would be a great time to discuss some of the new research and technological advnaces that have been in made in the treatment options for women with early stage Breast Cancer. No longer are the only choices for women with early stage Breast Cancer confined to mastectomy (loss of all breast tissue) or Whole Breast Irradiation (Radiation Therapy). Some of these new advances include Lumpectomy...
Another large topic specific to Breast Cancer is the use of digital mammography and its benefits versus the use of traditional film based mammography. There was a trial that was created in 2003 by the National Cancer Institute (NCI) called the Digital Mammographic Imaging Screening Trial, or better known or referred to as the DMIST Trial. This trial reached its enrollment target goal of 49,500 women in the U.S. and Canada. The trial is officially...
Well today is Monday and the very first day of October. Along with the new month and my birthday also comes the kick off of National Breast Cancer Awareness Month. There is a lot of information on the web about Breast Cancer, what it is, statistics, treatment options, support groups and what not, and I might be repeating what some other sites have already published, but I am going to be talking about topics that...
As the turn of the clock continues we see ourselves leaving September behind and moving into the fall a bit more. We begin fall by kicking off September with Prostate Cancer Awareness and the beginning of football. As we roll into October, we move into the end of baseball and Breast Cancer Awareness Month. Which means that as October 1 rolls in on Monday, so will my topics change. I will begin a month long...
Well today I am going to be explaining what Cryotherapy, Cryosurgery, or Cryoablation is and what it does for prostate cancer. This procedure can be referred to as all of the following, but for the purpose of my writing, I am going to just refer to it as cryosurgery. So cryosurgery simply means the application of extreme cold to destroy diseased tissue, in this case, prostate cancer. Physicians have been using this technology since the 1960's....
In an article out of Reuters from the 25th of Spetember, it was reported that AstraZeneca gave a report at the Eastern Society for Therapeutic Radiation Oncology (Barcelona, Spain) that there drug ZD4054 has shown to extend the lives of patients with advanced prostate cancer by as much as 7 months. In a statement released in July of this year by AstraZeneca stated that ZD4054 demonstrated overall survival benefits and was going to be moved to...